Aligos Therapeutics, Inc. (ALGS) Revenue 2020–2025
Aligos Therapeutics, Inc. (ALGS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$2.2MFY2025 · since FY2020: $0 → $2.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2M | -39.5% |
| FY2024 | $3.6M | -41.7% |
| FY2023 | $6.2M | — |
| FY2022 | $0 | — |
| FY2021 | $0 | — |
| FY2020 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice